Correlations Between Digit Ratio and Foetal Origins of Adult Diseases in a Chinese Population: A Focus on Coronary Heart Disease and Breast Cancer

2012 ◽  
pp. 853-865 ◽  
Author(s):  
Huo Zhenghao ◽  
Lu Hong ◽  
Dang Jie ◽  
Francis L. Martin
Keyword(s):  
Breast Cancer ◽  
Coronary Heart Disease ◽  
Heart Disease ◽  
Chinese Population ◽  
Digit Ratio

Second to fourth digit ratio (2D:4D) and coronary heart disease

2015 ◽  
Vol 91 (7) ◽  
pp. 417-420 ◽  
Author(s):  
Hong Lu ◽  
Zhanbing Ma ◽  
Junli Zhao ◽  
Zhenghao Huo
Keyword(s):  
Coronary Heart Disease ◽  
Heart Disease ◽  
Digit Ratio ◽  
Fourth Digit

scholarly journals Contribution of CYP24A1 variants in coronary heart disease among the Chinese population

2020 ◽  
Vol 19 (1) ◽  
Author(s):  
Peng Qian ◽  
Xuanchao Cao ◽  
Xianjing Xu ◽  
Mingqin Duan ◽  
Qian Zhang ◽  
...  
Keyword(s):  
Coronary Heart Disease ◽  
Heart Disease ◽  
Chinese Population

scholarly journals AGT gene polymorphisms (M235T, T174M) are associated with coronary heart disease in a Chinese population

2012 ◽  
Vol 14 (4) ◽  
pp. 354-359 ◽  
Author(s):  
Xingsheng Li ◽  
Qiao Li ◽  
Yongming Wang ◽  
Yizhen Li ◽  
Ming Ye ◽  
...  
Keyword(s):  
Coronary Heart Disease ◽  
Heart Disease ◽  
Gene Polymorphisms ◽  
Chinese Population ◽  
Agt Gene

Nonoccupational Exposure to Pyrethroids and Risk of Coronary Heart Disease in the Chinese Population

2016 ◽  
Vol 51 (1) ◽  
pp. 664-670 ◽  
Author(s):  
Jiajun Han ◽  
Liqin Zhou ◽  
Mai Luo ◽  
Yiran Liang ◽  
Wenting Zhao ◽  
...  
Keyword(s):  
Coronary Heart Disease ◽  
Heart Disease ◽  
Chinese Population

scholarly journals Randomized Trial Evaluation of Benefits and Risks of Menopausal Hormone Therapy Among Women Aged 50-59

2020 ◽  
Author(s):  
Ross L Prentice ◽  
Aaron K Aragaki ◽  
Rowan T Chlebowski ◽  
Jacques E Rossouw ◽  
Garnet L Anderson ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Coronary Heart Disease ◽  
Endometrial Cancer ◽  
Heart Disease ◽  
Hip Fracture ◽  
Global Index ◽  
All Cause Mortality ◽  
Conjugated Equine Estrogens ◽  
Equine Estrogens

Abstract The health benefits and risks of menopausal hormone therapy among women aged 50-59 years are examined in the Women’s Health Initiative randomized, placebo-controlled trials using long-term follow-up data and a parsimonious statistical model that leverages data from older participants to increase precision. These trials enrolled 27,347 healthy post-menopausal women aged 50-79 at 40 U.S. clinical centers during 1993-1998, including 10,739 post-hysterectomy participants in a trial of conjugated equine estrogens, and 16,608 participants with uterus in the trial of these estrogens plus medroxyprogesterone acetate. Over an 18-year (median) follow-up period (1993-2016) risk for a global index, defined as the earliest of coronary heart disease, invasive breast cancer, stroke, pulmonary embolism, colorectal cancer, endometrial cancer, hip fracture, and all-cause mortality, is reduced with conjugated equine estrogens with hazard ratio (95% confidence interval) of 0.82 (0.71, 0.95), and with nominally significant reductions for coronary heart disease, breast cancer, hip fracture and all-cause mortality. Corresponding global index hazard ratio estimates of 1.06 (0.95, 1.19) were non-significant for combined estrogens plus progestin, but increased breast cancer risk and reduced endometrial cancer risk were observed. These results, among women 50-59, substantially agree with the worldwide observational literature, with the exception of breast cancer for estrogens alone.

Sign in / Sign up

Export Citation Format

Share Document